Opal Wealth Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.9K Buy
+256
New +$47.2K 0.01% 414
2025
Q3
Sell
-186
Closed -$23.4K 235
2025
Q2
$23.4K Sell
186
-5
-3% -$623 0.01% 537
2025
Q1
$26.1K Buy
+191
New +$27.3K 0.01% 474
2024
Q3
Sell
-197
Closed -$45.7K 299
2024
Q2
$45.7K Buy
+197
New +$42.8K 0.01% 365

Other funds holding BIIB

Opal Wealth Advisors's BIIB Position: Q1 2026 in Review

Opal Wealth Advisors opened a new position in Biogen (BIIB) in Q1 2026: 256 shares worth $46.9K. The stake represents 0.01% of the portfolio and ranks #414 among its holdings. This is a return to the name: Opal Wealth Advisors previously reported a position in BIIB as recently as Q2 2025.

Opal Wealth Advisors first reported a position in BIIB in Q2 2024 and has held it in 4 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Opal Wealth Advisors held 256 shares of Biogen worth $46.9K as of Q1 2026.
  • Biogen was a new Opal Wealth Advisors position in Q1 2026.
  • Biogen made up 0.01% of Opal Wealth Advisors's portfolio in Q1 2026, its #414 holding.
  • Opal Wealth Advisors first reported a position in Biogen in Q2 2024 and has held it in 4 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.